Hjem › Diffust stort B-cellelymfom › District of Columbia › Washington
Kliniske studier for Diffust stort B-cellelymfom i Washington, DC
12 studier for Diffust stort B-cellelymfom søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RekruttererFase 2
- MedStar Georgetown University Hospital, Washington D.C.
- The Center for Cancer and Blood Disorders, Bethesda · 7 mi unna
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RekruttererFase 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi unna
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekruttererFase 1/2
- American Oncology Partners of Maryland Pa, Bethesda · 7 mi unna
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
RekruttererFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RekruttererFase 3
- American Oncology Partners, P.A. ( Site 0185), Bethesda · 7 mi unna
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RekruttererFase 2
- Georgetown University Medical Center ( Site 0117), Washington D.C.
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
RekruttererFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruttererFase 1/2
- Medstar Georgetown University Hospital, Washington D.C.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekruttererFase 3
- MedStar Georgetown University Hospital, Washington D.C.
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- National Institute of Health, Bethesda · 7 mi unna
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Diffust stort B-cellelymfom-studier i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Los Angeles, CA17 studier
- Houston, TX17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Portland, OR15 studier
- Nashville, TN15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
Andre studier i Washington
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft55 studier
- Brystkreft46 studier
- Metastatisk kreft43 studier
- Lungekreft41 studier
- Prostatakreft38 studier
- Fedme33 studier
- Kolorektal kreft29 studier
- Kardiovaskulær sykdom29 studier
- Blærekreft26 studier
- Akut myelogen leukemi24 studier
- Lymfom23 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.